Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha

J Immunol. 2004 Jun 15;172(12):7832-40. doi: 10.4049/jimmunol.172.12.7832.

Abstract

We previously demonstrated that GM-CSF/IFN-alpha combination allowed the differentiation of monocytes from HIV-infected patients into dendritic cells (DCs) exhibiting high CD8(+) T cell stimulating abilities. The present study was aimed at characterizing the ability of DCs generated in the presence of GM-CSF and IFN-alpha to induce CD4 T cell responses. DCs were generated from monocytes of HIV-infected patients in the presence of GM-CSF with either IFN-alpha (IFN-DCs) or IL-4 (IL-4-DCs) for 7 days. Eleven patients receiving highly active antiretroviral therapy and exhibiting CD4 cell counts above 400/mm(3) and plasma HIV-RNA <50 copies/ml for at least 1 year were included in the study. Both DC populations were found to be defective in inducing autologous (in response to tuberculin or HIV-p24) or allogeneic CD4 T cell proliferation. Neutralization of IL-10 during the differentiation of IFN-DCs, but not during the DC-T cell coculture, significantly increased their ability to stimulate autologous CD4 T cell proliferation in response to tuberculin and allogeneic CD4 T cell proliferation (4.1-fold and 3.0-fold increases, respectively, at the DC to T cell ratio of 1:10). Moreover, IL-10 neutralization and CD4(+)CD25(+) T cell depletion synergistically act to dramatically increase HIV-p24-specific CD4 T cell responses induced by IFN-DCs (31.7-fold increase) but not responses induced by IL-4-DCs. Taken together, our results indicate that IFN-DCs are more efficient than IL-4-DCs to stimulate CD4(+) T cell proliferation, further supporting their use for immune-based therapy in HIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen Presentation
  • Antiretroviral Therapy, Highly Active
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Culture Techniques / methods
  • Cell Differentiation
  • Cell Separation
  • Coculture Techniques
  • Dendritic Cells / immunology*
  • Dendritic Cells / metabolism
  • Dendritic Cells / pathology
  • HIV Core Protein p24 / immunology
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • Humans
  • Interferon-alpha / pharmacology
  • Interferon-gamma / biosynthesis
  • Interleukin-10 / biosynthesis*
  • Interleukin-10 / pharmacology
  • Interleukin-4 / biosynthesis
  • Lymphocyte Activation
  • Monocytes / pathology
  • Receptors, Interleukin-2 / analysis

Substances

  • HIV Core Protein p24
  • Interferon-alpha
  • Receptors, Interleukin-2
  • Interleukin-10
  • Interleukin-4
  • Interferon-gamma